← Back to Clinical Trials
Recruiting NCT06567106

NCT06567106 Investigation of Cardiac Function Following Low-Intensity Ultrasound Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06567106
Status Recruiting
Phase
Sponsor ShanghaiTech University
Condition Cardiac Function
Study Type INTERVENTIONAL
Enrollment 6 participants
Start Date 2024-10-10
Primary Completion 2027-10-10

Eligibility & Interventions

Sex Male only
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Ultrasound applicationNo ultrasound application

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 6 participants in total. It began in 2024-10-10 with a primary completion date of 2027-10-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to investigate the influence of ultrasound on cardiac functrion. The main question it aims to answer is: How will ultrasound affect the cardiac function? Researchers will: Apply ultrasound to the body and observe cardiac functions. Participants will: Receive ultrasound application and physiological signal monitoring.

Eligibility Criteria

Inclusion Criteria: * Healthy individuals without significant diseases or chronic conditions. * Aged between 18 and 65 years. * Voluntary participation with signed informed consent. * No history of cardiovascular disease. Exclusion Criteria: * Individuals with heart disease or other conditions that may affect cardiac function measurement. * Individuals with implanted electronic devices such as pacemakers or defibrillators. * Those on medications that significantly alter heart rate, such as beta-blockers, unless under stable control for a specific period. * Individuals at risk of severe complications.

Contact & Investigator

Central Contact

Bingbing Cheng, Ph.D.

✉ chengbb@shanghaitech.edu.cn

📞 +8620685173

Frequently Asked Questions

Who can join the NCT06567106 clinical trial?

This trial is open to male participants only, aged 18 Years or older, up to 65 Years, studying Cardiac Function. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06567106 currently recruiting?

Yes, NCT06567106 is actively recruiting participants. Contact the research team at chengbb@shanghaitech.edu.cn for enrollment information.

Where is the NCT06567106 trial being conducted?

This trial is being conducted at Shanghai, China.

Who is sponsoring the NCT06567106 clinical trial?

NCT06567106 is sponsored by ShanghaiTech University. The trial plans to enroll 6 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology